polycystic ovary syndrome
Conditions
Interventions
Sponsors
The Second Affiliated Hospital and Yuying Childrens Hospital of Wenzhou Medical University (WMU)
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1. Patients with polycystic ovary syndrome who meet the Rotterdam criteria. 2. Aged between 18 and 35. 3. No pharmacological intervention was performed within 3 months. 4. Agree to participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those who also suffer from other serious liver, kidney, cardiovascular, cerebrovascular, malignant tumor and genetic or familial disease. 2. Endocrine disorder such as thyroid hormone and diabetes. 3. Those who also suffer from endometriosis and other chronic autoimmune disease. 4. Other situations that researchers believe are not suitable for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Related cytokine levels and Th1/Th2 ratio;Fasting plasma glucose,Fasting insulin,HOMA-IR; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sex hormone: Follicle-stimulating hormone, Luteinizing hormone, estradiol, progesterone, testosterone, prolactin;Thyroid hormone: FT3, FT4, TSH;Blood routine examination;Height, weight, waist circumference, hip circumference; | — |
Countries
China
Contacts
Public ContactCheng Jing
The Second Affiliated Hospital and Yuying Childrens Hospital of Wenzhou Medical University (WMU)
Outcome results
None listed